Toleris Biotherapeutics
Pre-clinicalFounded in January 2024, Toleris Biotherapeutics is a pioneering biotech company based in Würzburg, Germany. Led by an experienced team of scientists and entrepreneurs, we specialize in developing first-in-class AutoImmunity Modifying Biologics (AIM Bios) - a breakthrough therapeutic approach that harnesses the body’s natural tolerance mechanism during pregnancy to treat autoimmune diseases.
About
Founded in January 2024, Toleris Biotherapeutics is a pioneering biotech company based in Würzburg, Germany. Led by an experienced team of scientists and entrepreneurs, we specialize in developing first-in-class AutoImmunity Modifying Biologics (AIM Bios) - a breakthrough therapeutic approach that harnesses the body’s natural tolerance mechanism during pregnancy to treat autoimmune diseases.
Funding History
2Total raised: $15.3M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile